AR060269A1 - Tiazolil-dihidro-quinazolinas, moduladoras de la pi3 quinasa, utiles para tratar enfermedades inflamatorias o alergicas, formulaciones farmaceuticas que las contienen y metodo de preparacion. - Google Patents
Tiazolil-dihidro-quinazolinas, moduladoras de la pi3 quinasa, utiles para tratar enfermedades inflamatorias o alergicas, formulaciones farmaceuticas que las contienen y metodo de preparacion.Info
- Publication number
- AR060269A1 AR060269A1 ARP070101387A ARP070101387A AR060269A1 AR 060269 A1 AR060269 A1 AR 060269A1 AR P070101387 A ARP070101387 A AR P070101387A AR P070101387 A ARP070101387 A AR P070101387A AR 060269 A1 AR060269 A1 AR 060269A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- cycloalkyl
- group
- radical
- optionally substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Ophthalmology & Optometry (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Otolaryngology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurology (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Formulaciones farmacéuticas que las contienen, método de preparacion y usos en terapia. Reivindicacion 1: Compuestos de la formula general (1) en los que significan A CH o N, n 1, 2, 3 o 4, R1 hidrogeno o un radical eventualmente sustituido, compuesto por alquilo C1-4, OR1,1 y NR1,1R1,2; R1,1, R1,2 iguales o diferentes, H o alquilo C1-4; o NR1,1R1,2 un heterociclo de 5 a 6 miembros, que eventualmente contiene otro átomo de N; R2 iguales o diferentes, hidrogeno o un radical seleccionado del grupo compuesto por F, Cl, Br, I, CN, CF3, CF2H, CFH2 y NH2; o un radical, eventualmente sustituido, seleccionado del grupo compuesto por -O-alquilo C1-4, alquilo C1-4 y alquenilo C2-6; R4 hidrogeno, OH, NH2 o un radical, eventualmente sustituido, seleccionado del grupo compuesto por alquilo C1-6, alquenilo C2-6, cicloalquilo C3-6, -N(alquilo C1-4)2 y -NH(alquilo C1-4); R3 un radical seleccionado del grupo compuesto por las formulas (2) en los que X un radical, eventualmente sustituido, seleccionado del grupo compuesto por alquileno C1-6, alquenileno C2-5, alquinileno C1-5, cicloalquileno C3-7, cicloalquenileno C5-7 y -alquilen C1-4-cicloalquileno C3-7, Y un enlace o X; R5, R6, R7 iguales o diferentes, hidrogeno o un radical, eventualmente sustituido, seleccionado del grupo compuesto por alquilo C1-6, alquenilo C2-6, alquinilo C2-6, haloalquilo C1-6, cicloalquilo C3-8, cicloalquenilo C3-8, cicloalquil C3-7-alquilo C1-4, arilo, heteroarilo, espiro, heterocicloalquilo, aril-alquilo C1-6, heteroaril-alquilo C1-6 y heterocicloalquil-alquilo C1-6, o NR6R7 forman un anillo de cinco, seis o siete miembros compuesto por átomos de carbono y eventualmente un átomo de nitrogeno, oxígeno o azufre como otros heteroátomos o un anillo seleccionado del grupo compuesto por formulas (3); R5,1 iguales diferentes, hidrogeno o un radical seleccionado del grupo compuesto por alquilo C1-6, cicloalquilo C3-8, -CO-alquilo C1-3 y CONH2; o R5 y R6 forman juntos un puente alquileno saturado o insaturado, que está eventualmente sustituido y que eventualmente puede contener otro átomo de nitrogeno, oxígeno o azufre; o R3 es igual a formula (4), x, y iguales o diferentes 0, 1, 2, 3, 4 o 5; W O, NR9 o CR9R10; R8 H, OR8,1, NR8,1R8,2 o alquilo C1-6 eventualmente sustituido; R8,1, R8,2 iguales o diferentes, hidrogeno, COR8,1,1, CONR8,1,1R8,1,2, SO2NR8,1,1R8,1,2 o SO2R8,1,1 o un radical, eventualmente sustituido, seleccionado del grupo compuesto por alquilo C1-6, alquenilo C3-6, alquinilo C3-6, cicloalquilo C3-8 y cicloalquil C3-7-alquilo C1-4, o NR8,1R8,2 forman juntos un anillo de cinco, seis o siete miembros que puede contener eventualmente otro heteroátomo; R8,1,1, R8,1,2 iguales o diferentes, hidrogeno o un radical, eventualmente sustituido, seleccionado del grupo compuesto por alquilo C1-6, cicloalquilo C3-8 y cicloalquil C3-7-alquilo C1-4, o NR8,1,1R8,1,2 forman juntos un anillo de cinco o seis miembros que eventualmente puede contener otro heteroátomo; R9, R10 iguales o diferentes, un radical eventualmente sustituido con OMe, CN, F, CI o Br, seleccionado del grupo compuesto por alquilo C1-6, alquenilo C2-6, alquinilo C2-6, cicloalquilo C3-8, cicloalquenilo C3-8, cicloalquil C3-7-alquilo C1-4, arilo, heteroarilo, espiro, heterocicloalquilo, aril-alquilo C7-11(aril-alquilo C1-6) y heteroaril-alquilo C6-10(heteroaril-alquilo C1-6); o R9, R10 iguales o diferentes, hidrogeno, COR9,1, CONR9,1R9,2, SO2R9,1 o SO2NR9,1R9,2; R9,1, R9,2 iguales o diferentes, hidrogeno o un radical eventualmente sustituido seleccionado del grupo compuesto por alquilo C1-6, alquenilo C2-6, alquinilo C2-6, haloalquilo C1-6, cicloalquiIo C3-8, cicloalquil C3-7-alquilo C1-4, arilo, heteroarilo, espiro, heterocicloalquilo, aril-alquilo C1-6 y heteroaril-alquilo C1-6; o NR9,1R9,2 forman juntos un anillo de cinco o seis miembros que eventualmente puede contener otro heteroátomo, eventualmente en forma de sus tautomeros, sus racematos, sus enantiomeros, sus diastereoisomeros y sus mezclas, así como eventualmente sus sales por adicion de ácidos, solvatos e hidratos farmacologicamente inocuos.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06112300 | 2006-04-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR060269A1 true AR060269A1 (es) | 2008-06-04 |
Family
ID=36790884
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP070101387A AR060269A1 (es) | 2006-04-06 | 2007-04-03 | Tiazolil-dihidro-quinazolinas, moduladoras de la pi3 quinasa, utiles para tratar enfermedades inflamatorias o alergicas, formulaciones farmaceuticas que las contienen y metodo de preparacion. |
Country Status (18)
Country | Link |
---|---|
US (2) | US7691868B2 (es) |
EP (1) | EP2018385B1 (es) |
JP (1) | JP5303450B2 (es) |
KR (1) | KR20090029181A (es) |
CN (2) | CN101460505B (es) |
AR (1) | AR060269A1 (es) |
AU (1) | AU2007236043B2 (es) |
BR (1) | BRPI0710575A2 (es) |
CA (1) | CA2647056A1 (es) |
DK (1) | DK2018385T3 (es) |
ES (1) | ES2425051T3 (es) |
IL (1) | IL194490A0 (es) |
MX (1) | MX2008011957A (es) |
NZ (1) | NZ572508A (es) |
RU (1) | RU2008143546A (es) |
TW (1) | TW200804402A (es) |
WO (1) | WO2007115929A1 (es) |
ZA (1) | ZA200807349B (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7691868B2 (en) | 2006-04-06 | 2010-04-06 | Boehringer Ingelheim International Gmbh | Thiazolyl-dihydro-quinazoline |
US20070259855A1 (en) * | 2006-04-06 | 2007-11-08 | Udo Maier | Thiazolyl-dihydro-indazole |
US20070238746A1 (en) * | 2006-04-06 | 2007-10-11 | Trixi Brandl | Thiazolyl-dihydro-chinazoline |
WO2010024258A1 (ja) * | 2008-08-29 | 2010-03-04 | 塩野義製薬株式会社 | Pi3k阻害活性を有する縮環アゾール誘導体 |
US20120071475A1 (en) * | 2009-04-27 | 2012-03-22 | Shionogi & Co., Ltd. | Urea derivatives having pi3k-inhibiting activity |
ES2432671T3 (es) * | 2009-07-02 | 2013-12-04 | Novartis Ag | 2-carboxamida cicloamino ureas útiles como inhibidores de PI3K |
US11633399B2 (en) | 2018-12-25 | 2023-04-25 | Sol-Gel Technologies Ltd. | Treatment of skin disorders with compositions comprising an EGFR inhibitor |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US238730A (en) * | 1881-03-08 | Wagon-brake | ||
US259855A (en) * | 1882-06-20 | Fbank s | ||
US244104A (en) * | 1881-07-12 | andrews | ||
US238718A (en) * | 1881-03-08 | Efeico eosenzi | ||
US4380640A (en) * | 1980-01-21 | 1983-04-19 | Ciba-Geigy Corporation | Novel benzthiazolylurea derivatives, compositions containing them and their use as herbicides |
BR0108085A (pt) * | 2000-02-07 | 2003-03-18 | Abbott Gmbh & Co Kg | Derivados de 2-benzotiazolil uréia e seu uso como inibidores da cinase protéica |
US20040009613A1 (en) * | 2001-02-16 | 2004-01-15 | Ming-Ming Zhou | Methods of identifying modulators of bromodomains |
US6608053B2 (en) * | 2000-04-27 | 2003-08-19 | Yamanouchi Pharmaceutical Co., Ltd. | Fused heteroaryl derivatives |
MY156407A (en) | 2002-02-28 | 2016-02-26 | Novartis Ag | 5-phenylthiazole derivatives and use as p13 kinase inhibitors |
BR0312752A (pt) | 2002-07-10 | 2005-04-26 | Applied Research Systems | Derivados de benzeno fundido de azolidinona-vinil |
RU2326881C9 (ru) | 2002-09-30 | 2009-04-10 | Байер Фармасьютикалс Корпорейшн | Конденсированные производные азолпиримидина, обладающие свойствами ингибитора фосфатидилинозитол-3-киназы (pi3k) |
JP2006510661A (ja) | 2002-12-06 | 2006-03-30 | ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー | Pi3kの阻害剤としてのベンズオキサジン−3−オン類及びその誘導体 |
BR0317572A (pt) | 2002-12-20 | 2005-11-22 | Warner Lambert Co | Benzoxazinas e seus derivados como inibidores de pi3ks |
CN1823067A (zh) | 2003-06-13 | 2006-08-23 | 赞塔里斯有限公司 | 具有抑制磷脂酰肌醇3-激酶活性的化合物及其使用方法 |
GB0315966D0 (en) | 2003-07-08 | 2003-08-13 | Cyclacel Ltd | Compounds |
CN1897950A (zh) | 2003-10-14 | 2007-01-17 | 惠氏公司 | 稠合芳基和杂芳基衍生物及其使用方法 |
UY29149A1 (es) | 2004-10-07 | 2006-05-31 | Boehringer Ingelheim Int | Tiazolil-dihidro-indazoles |
EP1802636B1 (de) * | 2004-10-07 | 2013-03-27 | Boehringer Ingelheim International Gmbh | Pi3-kinasen inhibitoren |
US20070238718A1 (en) | 2006-04-06 | 2007-10-11 | Matthias Grauert | Thiazolyl-dihydro-indazole |
US20070238746A1 (en) * | 2006-04-06 | 2007-10-11 | Trixi Brandl | Thiazolyl-dihydro-chinazoline |
US20070259855A1 (en) | 2006-04-06 | 2007-11-08 | Udo Maier | Thiazolyl-dihydro-indazole |
US7691868B2 (en) | 2006-04-06 | 2010-04-06 | Boehringer Ingelheim International Gmbh | Thiazolyl-dihydro-quinazoline |
US7517995B2 (en) | 2006-04-06 | 2009-04-14 | Boehringer Ingelheim International Gmbh | Thiazolyl-dihydro-cyclopentapyrazole |
-
2007
- 2007-03-23 US US11/690,362 patent/US7691868B2/en active Active
- 2007-03-27 KR KR1020087027076A patent/KR20090029181A/ko not_active Application Discontinuation
- 2007-03-27 ES ES07727385T patent/ES2425051T3/es active Active
- 2007-03-27 CN CN2007800207880A patent/CN101460505B/zh not_active Expired - Fee Related
- 2007-03-27 MX MX2008011957A patent/MX2008011957A/es active IP Right Grant
- 2007-03-27 EP EP07727385.2A patent/EP2018385B1/de not_active Not-in-force
- 2007-03-27 AU AU2007236043A patent/AU2007236043B2/en not_active Ceased
- 2007-03-27 BR BRPI0710575-4A patent/BRPI0710575A2/pt not_active IP Right Cessation
- 2007-03-27 RU RU2008143546/04A patent/RU2008143546A/ru not_active Application Discontinuation
- 2007-03-27 WO PCT/EP2007/052912 patent/WO2007115929A1/de active Application Filing
- 2007-03-27 NZ NZ572508A patent/NZ572508A/en not_active IP Right Cessation
- 2007-03-27 CN CN201310049412XA patent/CN103172589A/zh active Pending
- 2007-03-27 CA CA002647056A patent/CA2647056A1/en not_active Abandoned
- 2007-03-27 JP JP2009503532A patent/JP5303450B2/ja not_active Expired - Fee Related
- 2007-03-27 DK DK07727385.2T patent/DK2018385T3/da active
- 2007-04-03 AR ARP070101387A patent/AR060269A1/es unknown
- 2007-04-04 TW TW096111946A patent/TW200804402A/zh unknown
-
2008
- 2008-08-26 ZA ZA200807349A patent/ZA200807349B/xx unknown
- 2008-10-02 IL IL194490A patent/IL194490A0/en unknown
-
2010
- 2010-02-17 US US12/706,936 patent/US8334378B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
AU2007236043A1 (en) | 2007-10-18 |
IL194490A0 (en) | 2009-08-03 |
WO2007115929A8 (de) | 2008-06-19 |
CN101460505B (zh) | 2013-03-20 |
JP5303450B2 (ja) | 2013-10-02 |
CN103172589A (zh) | 2013-06-26 |
CN101460505A (zh) | 2009-06-17 |
US20070244104A1 (en) | 2007-10-18 |
ZA200807349B (en) | 2009-07-29 |
EP2018385A1 (de) | 2009-01-28 |
EP2018385B1 (de) | 2013-05-15 |
WO2007115929A1 (de) | 2007-10-18 |
US20100145041A1 (en) | 2010-06-10 |
US7691868B2 (en) | 2010-04-06 |
CA2647056A1 (en) | 2007-10-18 |
BRPI0710575A2 (pt) | 2012-06-19 |
TW200804402A (en) | 2008-01-16 |
ES2425051T3 (es) | 2013-10-11 |
JP2009532413A (ja) | 2009-09-10 |
DK2018385T3 (da) | 2013-08-26 |
MX2008011957A (es) | 2008-10-01 |
RU2008143546A (ru) | 2010-06-27 |
AU2007236043B2 (en) | 2012-09-13 |
NZ572508A (en) | 2011-11-25 |
KR20090029181A (ko) | 2009-03-20 |
US8334378B2 (en) | 2012-12-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR060269A1 (es) | Tiazolil-dihidro-quinazolinas, moduladoras de la pi3 quinasa, utiles para tratar enfermedades inflamatorias o alergicas, formulaciones farmaceuticas que las contienen y metodo de preparacion. | |
AR069510A1 (es) | Arilo y heteroarilo imidazo[1,5-a]pirazinas fusionadas como inhibidores de la fosfodiesterasa 10 | |
AR070469A1 (es) | Derivados de naftiridina y composiciones farmaceuticas como inhibidores de quinasa con actividad sobre c- kit y pdgfr | |
AR085960A1 (es) | 1,3-oxazinas como inhibidores de la bace1 y/o de la bace2 | |
AR053092A1 (es) | Compuestos derivados de acido fenoxiacetico y compuestos intermediarios de sintesis | |
AR033295A1 (es) | Compuestos biciclicos de pirimidina, proceso para su obtencion, uso de los mismos para la preparacion de una composicion farmaceutica y dicha composicion farmaceutica | |
AR054560A1 (es) | Espiropiperidina como inhibidores de beta-secretasa para el tratamiento de la enfermedad de alzheimer | |
AR081577A1 (es) | Derivados de aminopirimidina como moduladores de la lrrk2 | |
AR077463A1 (es) | Derivados de imidazo[1, 2 - a]pirazina y su uso en medicamentos para el tratamiento de enfermedades parasitarias | |
AR045082A1 (es) | Compuestos de aminobenzofenona y su uso en tratamientos terapeuticos | |
AR086983A1 (es) | Derivados de azetidinil fenil, piridil o pirazinil carboxamida como inhibidores de jak | |
AR067886A1 (es) | Derivados de acido azabifenilaminobenzoico | |
AR076486A1 (es) | Inhibidores de fosfoinositida 3 kinasa y composiciones farmaceuticas que los contienen. | |
CO6251251A2 (es) | Derivados de pirazinona y su uso en el tratamiento de enfermedades pulmonares | |
AR061548A1 (es) | 3-aminopirrolidino-4-lactamas sustituidas como inhibidoras de dipeptidilpeptidasa iv (dpp-iv), composiciones farmaceuticas que las comprenden y el uso de las mismas en el tratamiento de la diabetes ii. | |
AR070520A1 (es) | Derivados de azuleno nitrogenados,composiciones farmaceuticas que los contienen,proceso de preparacion y usos de los mismos para tratar trastornos metabolicos y digestivos,entre otros. | |
AR086086A1 (es) | Derivados glucosidos y usos de los mismos | |
AR050611A1 (es) | Derivados de dihidripteridinona | |
AR050610A1 (es) | Derivados de dihidropteridinona | |
AR076936A1 (es) | Inhibidores de carbamato y urea de la 11 beta hidroxiesteroide deshidrogenasa 1 | |
AR084507A1 (es) | Derivados de indazoliltriazol | |
AR060265A1 (es) | Tiazolil - dihidro -quinazolinas | |
AR055744A1 (es) | Derivados de acido pirimidincarboxilico, su uso para preparar medicamentos y preparacion de dicjhos compuestos | |
AR069509A1 (es) | Pirido (3,2-e) pirazinas, su procedimiento de preparacion y uso como inhibidores de fosfodiesterasa 10 | |
AR076236A1 (es) | Compuestos organicos y sus usos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |